Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false, so the description's edge-case disclosure is additive rather than redundant. It flags the USPTO PatentsView API sunset and soft-fail behavior, warns that a company with only small-molecule/generic drugs will show an empty fda_products section as expected, and explains that empty sections are real 'no data,' not bugs. It also discloses private-company resolved:false behavior and name resolution via SEC EDGAR.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with intent and examples, but it is also one dense, run-on paragraph mixing sources, return fields, edge cases, and input semantics. Every clause adds some value, but the lack of structural organization makes it harder to scan than it should be for such a behavior-rich tool.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return values and largely succeeds, listing keys like cik, company_name, resolved_from/to, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, sources_used, and sources_failed, plus details like pipeworx URIs and period sorting. It also covers expected absences, soft failures, and private-company behavior, making it complete enough for an agent to invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already covers 100% of the parameters with descriptions and examples, so the baseline is 3. The description adds meaning by clarifying that `type` accepts 'company' or 'ticker' interchangeably, that `value` can be a ticker, zero-padded CIK, or company name, and that a private company resolves to false with a notes line—useful supplementary detail beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States that it returns a 'full cross-source profile of a US public company in ONE parallel call,' enumerating specific resources like SEC EDGAR, XBRL, USPTO, USAspending, FDA Purple Book, DOL LCA, and GLEIF. It also explicitly distinguishes itself from 'chaining single-pack SEC/XBRL/news lookups' with 'ALWAYS PREFER,' so an agent can tell it apart from related tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says to prefer this tool over chaining single-pack lookups when the user asks for a holistic view, and provides many natural-language invocation examples. It also defines accepted input shapes and private-company behavior, though it does not name sibling tools like deep_research or compare_entities or state when those should be used instead.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation4/5

Most tools have clearly distinct purposes, but ask_pipeworx and ask_pipeworx_grounded are very similar and could cause confusion. The multiple Polymarket tools are differentiated by their specific functions.

Naming Consistency3/5

Tool names are a mix of verb_noun (e.g., ask_pipeworx, get_verse) and noun_verb (e.g., polymarket_arbitrage, ai_visibility_check). While all use snake_case, the pattern is inconsistent.

Tool Count4/5

With 33 tools, the server is comprehensive but slightly large. Each tool seems justified, covering multiple domains like company data, prediction markets, Bible, and memory.

Completeness5/5

The tool surface is highly complete for a universal data server, including financials, drugs, patents, news, real estate, and more. Meta-tools like discover_tools and suggest_questions further enhance usability.